# First Financial Bankshares Inc: financial statements, quarterly

FFIN · Nasdaq · CIK 36029 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ffin.md) · [Financials](/companies/ffin/financials.md) · [Filings](/companies/ffin/filings.md) · [Insiders](/companies/ffin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ffin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [41.2](/filings/0000950170-23-059352.md) | [44.7 d](/filings/0000950170-24-019528.md) | [49.3](/filings/0000950170-24-052911.md) | [50.4](/filings/0000950170-24-088521.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.8](/filings/0000950170-24-120653.md) | [10.0 d](/filings/0001193125-26-071549.md) | [11.5](/filings/0000950170-25-064146.md) | [11.2](/filings/0000950170-25-101314.md) | [12.0](/filings/0001193125-25-272373.md) | [13.7 d](/filings/0001193125-26-071549.md) | [13.8](/filings/0001193125-26-206412.md) | [15.1](/filings/0001193125-26-333027.md) | [10.9](/filings/0001193125-25-272373.md) | [16.2 d](/filings/0001193125-26-071549.md) | [16.3](/filings/0001193125-26-206412.md) | [15.6](/filings/0001193125-26-333027.md) |
| Net income | $m | [49.6](/filings/0000950170-24-120653.md) | [46.0 d](/filings/0001193125-26-071549.md) | [53.4](/filings/0000950170-25-064146.md) | [52.5](/filings/0000950170-25-101314.md) | [55.3](/filings/0001193125-25-272373.md) | [62.3 d](/filings/0001193125-26-071549.md) | [61.3](/filings/0001193125-26-206412.md) | [66.7](/filings/0001193125-26-333027.md) | [52.3](/filings/0001193125-25-272373.md) | [73.3 d](/filings/0001193125-26-071549.md) | [71.5](/filings/0001193125-26-206412.md) | [71.9](/filings/0001193125-26-333027.md) |
| Diluted EPS | $ per share | [0.35](/filings/0000950170-24-120653.md) | not reported | [0.37](/filings/0000950170-25-064146.md) | [0.37](/filings/0000950170-25-101314.md) | [0.39](/filings/0001193125-25-272373.md) | not reported | [0.43](/filings/0001193125-26-206412.md) | [0.47](/filings/0001193125-26-333027.md) | [0.36](/filings/0001193125-25-272373.md) | not reported | [0.50](/filings/0001193125-26-206412.md) | [0.50](/filings/0001193125-26-333027.md) |
| Basic EPS | $ per share | [0.35](/filings/0000950170-24-120653.md) | not reported | [0.37](/filings/0000950170-25-064146.md) | [0.37](/filings/0000950170-25-101314.md) | [0.39](/filings/0001193125-25-272373.md) | not reported | [0.43](/filings/0001193125-26-206412.md) | [0.47](/filings/0001193125-26-333027.md) | [0.37](/filings/0001193125-25-272373.md) | not reported | [0.50](/filings/0001193125-26-206412.md) | [0.50](/filings/0001193125-26-333027.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [12.8](/filings/0000950170-24-120653.md) | [13.1](/filings/0000950170-25-024666.md) | [13.2](/filings/0000950170-25-064146.md) | [13.2](/filings/0000950170-25-101314.md) | [13.6](/filings/0001193125-25-272373.md) | [14.0](/filings/0001193125-26-071549.md) | [14.3](/filings/0000950170-25-064146.md) | [14.4](/filings/0000950170-25-101314.md) | [14.8](/filings/0001193125-25-272373.md) | [15.4](/filings/0001193125-26-333027.md) | [15.4](/filings/0001193125-26-206412.md) | [15.3](/filings/0001193125-26-333027.md) |
| Total liabilities | $bn | [11.5](/filings/0000950170-24-120653.md) | [11.6](/filings/0000950170-25-024666.md) | [11.7](/filings/0000950170-25-064146.md) | [11.6](/filings/0000950170-25-101314.md) | [11.9](/filings/0001193125-25-272373.md) | [12.4](/filings/0001193125-26-071549.md) | [12.6](/filings/0000950170-25-064146.md) | [12.6](/filings/0000950170-25-101314.md) | [13.0](/filings/0001193125-25-272373.md) | [13.5](/filings/0001193125-26-333027.md) | [13.4](/filings/0001193125-26-206412.md) | [13.3](/filings/0001193125-26-333027.md) |
| Short-term borrowings | $bn | [0.1](/filings/0000950170-24-120653.md) | [0.0](/filings/0000950170-25-024666.md) | [0.0](/filings/0000950170-25-064146.md) | [0.0](/filings/0000950170-25-101314.md) | [0.0](/filings/0001193125-25-272373.md) | [0.1](/filings/0001193125-26-071549.md) | [0.0](/filings/0000950170-25-064146.md) | [0.0](/filings/0000950170-25-101314.md) | [0.0](/filings/0001193125-25-272373.md) | [0.0](/filings/0001193125-26-333027.md) | [0.0](/filings/0001193125-26-206412.md) | [0.0](/filings/0001193125-26-333027.md) |
| Shareholders' equity | $bn | [1.2](/filings/0000950170-24-120653.md) | [1.5](/filings/0001193125-26-071549.md) | [1.5](/filings/0000950170-25-101314.md) | [1.5](/filings/0001193125-25-272373.md) | [1.7](/filings/0001193125-25-272373.md) | [1.6](/filings/0001193125-26-333027.md) | [1.7](/filings/0001193125-26-333027.md) | [1.7](/filings/0001193125-26-333027.md) | [1.8](/filings/0001193125-25-272373.md) | [1.9](/filings/0001193125-26-333027.md) | [1.9](/filings/0001193125-26-333027.md) | [2.0](/filings/0001193125-26-333027.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [73.1 d](/filings/0000950170-24-120653.md) | [58.7 d](/filings/0001193125-26-071549.md) | [75.6](/filings/0000950170-25-064146.md) | [68.8 d](/filings/0000950170-25-101314.md) | [80.7 d](/filings/0001193125-25-272373.md) | [84.5 d](/filings/0001193125-26-071549.md) | [76.8](/filings/0001193125-26-206412.md) | [61.3 d](/filings/0001193125-26-333027.md) | [86.5 d](/filings/0001193125-25-272373.md) | [74.9 d](/filings/0001193125-26-071549.md) | [102](/filings/0001193125-26-206412.md) | [83.7 d](/filings/0001193125-26-333027.md) |
| Capital expenditure | $m | [4.4 d](/filings/0000950170-24-120653.md) | [3.9 d](/filings/0001193125-26-071549.md) | [3.9](/filings/0000950170-25-064146.md) | [5.0 d](/filings/0000950170-25-101314.md) | [3.1 d](/filings/0001193125-25-272373.md) | [4.8 d](/filings/0001193125-26-071549.md) | [2.1](/filings/0001193125-26-206412.md) | [2.6 d](/filings/0001193125-26-333027.md) | [2.8 d](/filings/0001193125-25-272373.md) | [6.0 d](/filings/0001193125-26-071549.md) | [4.1](/filings/0001193125-26-206412.md) | [8.5 d](/filings/0001193125-26-333027.md) |
| Dividends paid | $m | [25.7 d](/filings/0000950170-24-120653.md) | [25.7 d](/filings/0001193125-26-071549.md) | [25.7](/filings/0000950170-25-064146.md) | [25.7 d](/filings/0000950170-25-101314.md) | [25.7 d](/filings/0001193125-25-272373.md) | [25.7 d](/filings/0001193125-26-071549.md) | [25.8](/filings/0001193125-26-206412.md) | [25.8 d](/filings/0001193125-26-333027.md) | [27.2 d](/filings/0001193125-25-272373.md) | [27.3 d](/filings/0001193125-26-071549.md) | [27.2](/filings/0001193125-26-206412.md) | [27.3 d](/filings/0001193125-26-333027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [143](/filings/0000950170-23-059352.md) | [143](/filings/0000950170-24-052911.md) | [143](/filings/0000950170-24-088521.md) | [143](/filings/0000950170-24-120653.md) | [143](/filings/0000950170-25-064146.md) | [143](/filings/0000950170-25-101314.md) | [143](/filings/0001193125-25-272373.md) | [143](/filings/0001193125-26-206412.md) | [143](/filings/0001193125-26-333027.md) | [143](/filings/0001193125-25-272373.md) | [144](/filings/0001193125-26-206412.md) | [144](/filings/0001193125-26-333027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 143,327,507 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-333027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.